Anti-CD20 monoclonal antibodies, low risk of pyoderma gangrenosum

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-025-75282-z
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [2] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [3] Anti-CD20 monoclonal antibodies: reviewing a revolution
    Casan, J. M. L.
    Wong, J.
    Northcott, M. J.
    Opat, S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2820 - 2841
  • [4] Mechanisms of killing by anti-CD20 monoclonal antibodies
    Glennie, Martin J.
    French, Ruth R.
    Cragg, Mark S.
    Taylor, Ronald P.
    MOLECULAR IMMUNOLOGY, 2007, 44 (16) : 3823 - 3837
  • [5] Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (04) : 444 - 449
  • [6] Anti-CD20 monoclonal antibodies: historical and future perspectives
    Lim, Sean H.
    Beers, Stephen A.
    French, Ruth R.
    Johnson, Peter W. M.
    Glennie, Martin J.
    Cragg, Mark S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (01): : 135 - 143
  • [7] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Jain, Preetesh
    O'Brien, Susan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 169 - 182
  • [8] Chronic Lymphocytic Leukemia and anti-CD20 monoclonal antibodies
    Reslan, Lina
    Dalle, Stephane
    Mestas, Jean-Louis
    Tournebize, Cindy
    Dumontet, Charles
    BULLETIN DU CANCER, 2010, 97 : S60 - S60
  • [9] New anti-CD20 monoclonal antibodies: which is the best?
    Gagez, Anne-Laure
    Cartron, Guillaume
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 1 - 2
  • [10] Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus
    Shah, Kavina
    Cragg, Mark
    Leandro, Maria
    Reddy, Venkat
    BIOLOGICALS, 2021, 69 : 1 - 14